Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes

Dalle, JH; Balduzzi, A; Bader, P; Lankester, A; Yaniv, I; Wachowiak, J; Pieczonka, A; Bierings, M; Yesilipek, A; Sedlacek, P; Ifversen, M; Sufliarska, S; Toporski, J; Glogova, E; Poetschger, U; Peters, C

Dalle, JH (reprint author), Robert Debre Hosp, Hematol Immunol Dept, 48 Blvd Serurier, F-75935 Paris 19, France.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018; 24 (9): 1848

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is beneficial for pediatric patients with relapsed or (very) high-risk acute lymphoblastic l......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索